TP53 and cancer: The Cis target KEGG (Fig. 5b) enrichment was mainly observed in pathways in cancer and the calcium signaling pathway, while the trans target KEGG (Additional file 3) B enrichment was observed in the p53 signaling pathway and Jak-STAT signaling pathway.